Volume 2, Number 5 (September/October 2004)

Bench to Bedside

377

  

Assessment and Treatment of Patients With Malignant Spinal Cord Compression
Janet L. Abrahm, MD

Departments of Medicine and Anesthesia, Harvard Medical School, and the Pain and Palliative Care Program, Dana-Farber Cancer Institute, Boston, Massachusetts

With peer viewpoints by Andrew Loblaw, MD, Department of Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada, and David Schiff, MD, Neuro-Oncology Center, University of Virginia Health Sciences Center, Charlottesville, Virginia

abstract full text 257 kb

405

  

Treatment of Brain Metastases
Teri Nguyen, MD, and Lisa M. DeAngelis, MD

Department of Neurology, Weill Medical College of Cornell University, New York, New York, and Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York

With peer viewpoints by J. Gregory Cairncross, MD, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada; David G. Kirsch, MD, PhD, and Jay S. Loeffler, MD, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; and Samuel T. Chao, MD, Steven A. Toms, MD, and John H. Suh, MD, Brain Tumor Institute, The Cleveland Clinic Foundation, Cleveland, Ohio

abstract full text 172 kb

419

  

Complementary Therapies for Cancer-Related Symptoms
Gary Deng, MD, PhD, Barrie R. Cassileth, PhD, and K. Simon Yeung, RPh, MBA, Lac

Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York

With peer viewpoints by Debu Tripathy, MD, Komen/UT Southwestern Breast Cancer Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas, and Patrick J. Mansky, MD, and Margaret A. Chesney, PhD, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland

abstract full text 170 kb

Original Research

439

  

Palliation of Soft Tissue Cancer Pain With Radiofrequency Ablation
Julia K. Locklin, RN, MS, Andrew Mannes, MD, Ann Berger, MD, and Bradford J. Wood, MD

National Institutes of Health, Warren G. Magnuson Clinical Center, Bethesda, Maryland

abstract full text 180 kb

How We Do It

447

  

Use of Atypical Antipsychotic Agents for Symptom Control in Patients With Advanced Cancer
Michael J. Fisch, MD, MPH, and H. Florence Kim, MD

Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, andMenninger Department of Psychiatry, Baylor College of Medicine, Houston, Texas

full text 94 kb

How We Say It

455

  

Silence as the Speech of Care
By Corrina Lee, RN, BSN, and Richard T. Penson, MRCP, MD

Divisions of Hematology and Oncology and Gynecologic Oncology, Massachusetts General Hospital, Boston, Massachusetts

full text 58 kb

Clinical Trials

453

  

Clinical Trials in Supportive Care
Complementary Therapies

full text 48 kb

Reports from the LENT V Workshop

431

  

Four Initiatives Proposed to Improve Safety Reporting in Clinical Trials

full text 55 kb

432

  

New Software to Facilitate Clinical Trials Safety Reporting

full text 55 kb

433

  

Hypoxia-Mediated Chronic Normal Tissue Injury

full text 56 kb

437

  

Late Effects of Ionizing Irradiation in the Lung

full text 52 kb

Observations

416

  

Patient-Reported Fatigue Scores Reflect Physical Function Impairment

full text 31 kb

452

  

Baseline Patient Factors Predict Response to Erythropoietic Therapy

full text 33 kb

456

  

Higher Costs May Justify Prophylaxis in Prostate and Lung Cancer Patients With Bone Metastases

full text 35 kb

Reader Services

374

  

Guide for Authors

© 2004 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.